在抑郁症缓解后的患者中,抗抑郁药治疗后的人口因素和大脑等级变化之间的关系
Li Xue1, Huan Wang1, Xinyi Wang1
1School of Biological Sciences & Medical Engineering, Southeast University, Nanjing, 210096, China; Child Development and Learning Science, Key Laboratory of Ministry of Education, China.
Journal of psychiatric research
|December 11, 2024
概括
诸如年龄等人口因素会影响大抑郁症 (MDD) 患者的脑部变化,这些患者接受选择性血清素再吸收抑制剂 (SSRI) 治疗. 发病年龄也会调节大脑网络变化与MDD症状改善的关系.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 重度抑郁症 (MDD) 是一种普遍存在的精神健康状况,具有复杂的神经生物学基础.
- 选择性血清素再吸收抑制剂 (SSRI) 是MDD的常见药物治疗方法,但治疗反应可能有所不同.
- 了解人口因素如何影响治疗期间的大脑变化对于个性化医学至关重要.
研究的目的:
- 研究成功SSRI治疗后MDD患者的人口因素和大脑等级变化之间的关系.
- 确定年龄和发病年龄如何影响大脑网络变化和抑郁症症状恢复.
主要方法:
- 扩散张力成像 (DTI) 用于扫描57名MDD患者在SSRI治疗12周前后,以及39名健康对照 (HC).
- 梯度映射技术量化了功能性社区分散,定义了与HC相对的疾病和恢复模式.
- 抑郁症的严重程度使用汉密尔顿抑郁症评分表 (HAMD) 进行评估,包括抑郁症,认知障碍,焦虑和睡眠障碍的子表.
主要成果:
- 抑郁症的疾病模式与年龄有关,老年人表现出更严重的损伤.
- 在治疗前和治疗后的MDD患者之间观察到前对对面网络 (FPN) 分散的显著差异.
- 发病年龄调节了FPN分散和认知改善,背部注意力网络 (DAN) 分散和延迟改善之间的关联.
结论:
- 人口因素,特别是年龄和发病年龄,在SSRI治疗MDD期间对大脑层次变化起着重要作用.
- 这些发现强调了考虑人口统计学影响对于优化治疗抑郁症的临床疗效的重要性.
- 该研究提供了有关SSRI治疗反应的神经生物学机制的见解,与患者特征相关.
相关概念视频
01:27Depressive Disorders: Etiology
49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49
01:18Depression: Overview
215
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
215
01:23Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
01:30Attention-Deficit/Hyperactivity Disorder
40
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
40